MA32622B1 - Derives de carbonate de quinuclidine et composition medicinale les comprenant - Google Patents

Derives de carbonate de quinuclidine et composition medicinale les comprenant

Info

Publication number
MA32622B1
MA32622B1 MA33683A MA33683A MA32622B1 MA 32622 B1 MA32622 B1 MA 32622B1 MA 33683 A MA33683 A MA 33683A MA 33683 A MA33683 A MA 33683A MA 32622 B1 MA32622 B1 MA 32622B1
Authority
MA
Morocco
Prior art keywords
same
medicinal composition
carbonate derivatives
quinuclidine
quinuclidine carbonate
Prior art date
Application number
MA33683A
Other languages
Arabic (ar)
English (en)
Inventor
Gabriele Amari
Maurizio Delcanale
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MA32622B1 publication Critical patent/MA32622B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention porte sur des dérivés de carbonate de quinuclidine agissant en tant qu'antagonistes des récepteurs muscariniques, sur des procédés de préparation de tels dérivés, sur des compositions les comprenant et sur leur utilisation thérapeutique.
MA33683A 2008-08-08 2011-03-08 Derives de carbonate de quinuclidine et composition medicinale les comprenant MA32622B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08162066A EP2154136A1 (fr) 2008-08-08 2008-08-08 Dérivés de carbone de quinuclidine et ses compositions médicales
PCT/EP2009/005272 WO2010015324A1 (fr) 2008-08-08 2009-07-21 Dérivés de carbonate de quinuclidine et composition médicinale les comprenant

Publications (1)

Publication Number Publication Date
MA32622B1 true MA32622B1 (fr) 2011-09-01

Family

ID=40228074

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33683A MA32622B1 (fr) 2008-08-08 2011-03-08 Derives de carbonate de quinuclidine et composition medicinale les comprenant

Country Status (32)

Country Link
US (3) US8039483B2 (fr)
EP (2) EP2154136A1 (fr)
JP (1) JP2011530489A (fr)
KR (1) KR20110044221A (fr)
CN (1) CN102112474B (fr)
AR (1) AR072994A1 (fr)
AT (1) ATE551341T1 (fr)
AU (1) AU2009278306B2 (fr)
CA (1) CA2733380A1 (fr)
CO (1) CO6351790A2 (fr)
CY (1) CY1112724T1 (fr)
DK (1) DK2313404T3 (fr)
EA (1) EA019166B1 (fr)
ES (1) ES2384914T3 (fr)
GE (1) GEP20135744B (fr)
HK (1) HK1156032A1 (fr)
HR (1) HRP20120394T1 (fr)
IL (1) IL211103A (fr)
JO (1) JO2831B1 (fr)
MA (1) MA32622B1 (fr)
ME (1) ME01283A (fr)
MX (1) MX2011001504A (fr)
MY (1) MY156332A (fr)
NZ (1) NZ590987A (fr)
PL (1) PL2313404T3 (fr)
PT (1) PT2313404E (fr)
RS (1) RS52370B (fr)
SI (1) SI2313404T1 (fr)
TW (1) TWI455938B (fr)
UA (1) UA102857C2 (fr)
WO (1) WO2010015324A1 (fr)
ZA (1) ZA201100963B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2230934E (pt) 2007-12-14 2012-11-20 Aerodesigns Inc Distribuir produtos alimentares aerossolizáveis
EP2154136A1 (fr) 2008-08-08 2010-02-17 CHIESI FARMACEUTICI S.p.A. Dérivés de carbone de quinuclidine et ses compositions médicales
EP2206712A1 (fr) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. Dérivés d'amino-ester d'alcaloïde et sa composition médicale
EP2560611B1 (fr) 2010-04-21 2018-01-03 Chiesi Farmaceutici S.p.A. Procédé de préparation de particules ayant des charges électrostatiques réduites
CA2803459A1 (fr) 2010-06-22 2011-12-29 Chiesi Farmaceutici S.P.A. Derives aminoester d'alcaloides et compositions medicinales les comprenant
EP2585458B1 (fr) 2010-06-22 2015-01-07 Chiesi Farmaceutici S.p.A. Dérivés d'amino-ester d'alcaloïde et compositions médicales à base de ceux-ci
CN102947298B (zh) 2010-06-22 2016-03-02 奇斯药制品公司 生物碱氨基酯衍生物及其药物组合物
CA2813096C (fr) * 2010-09-30 2019-10-29 Chiesi Farmaceutici S.P.A. Utilisation de stearate de magnesium dans des preparations en poudre seche destinees a etre inhalees
KR20130140672A (ko) * 2010-10-20 2013-12-24 키에시 파르마슈티시 엣스. 피. 에이. 기침 치료용 카보네이트 유도체
RU2585767C2 (ru) 2010-11-26 2016-06-10 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Производные глицина и их применение в качестве антагонистов мускариновых рецепторов
JP6117708B2 (ja) * 2011-03-18 2017-04-19 ジェンザイム・コーポレーション グルコシルセラミド合成酵素阻害剤
RU2611627C2 (ru) * 2011-04-29 2017-02-28 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Алкалоидный эфир и карбаматные производные и их медицинские композиции
CN104011043B (zh) 2011-12-30 2016-11-16 奇斯药制品公司 作为抗毒蕈碱剂的1-氮杂杂环基乙酸的奎宁环酯、它们的制备方法及其药用组合物
MA37975B2 (fr) * 2012-09-11 2021-03-31 Genzyme Corp Inhibiteurs de synthase de glucosylcéramide
US9427376B2 (en) 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
BR112023000798A2 (pt) 2020-07-24 2023-02-07 Genzyme Corp Composições farmacêuticas compreendendo venglustat

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
IL156499A0 (en) 2000-12-22 2004-01-04 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
EP1383730A2 (fr) * 2001-04-03 2004-01-28 Aryx Therapeutics Composes anticholinergiques et procedes d'utilisation
MXPA04006206A (es) 2001-12-20 2004-12-06 S A L V A T Lab Sa Derivados de 1-alquil-azoniabiciclo(2.2.2(octano carbamato y su uso como antagonistas del receptor musrcarinico.
EP1882691A1 (fr) 2006-07-26 2008-01-30 CHIESI FARMACEUTICI S.p.A. Dérivés de quinuclidine comme antagonistes M3
EP2154136A1 (fr) 2008-08-08 2010-02-17 CHIESI FARMACEUTICI S.p.A. Dérivés de carbone de quinuclidine et ses compositions médicales
EP2206712A1 (fr) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. Dérivés d'amino-ester d'alcaloïde et sa composition médicale
AU2011269238A1 (en) 2010-06-22 2013-01-10 Chiesi Farmaceutici S.P.A. Dry powder formulation comprising an antimuscarinic drug
KR20130140672A (ko) 2010-10-20 2013-12-24 키에시 파르마슈티시 엣스. 피. 에이. 기침 치료용 카보네이트 유도체
US20120220557A1 (en) 2011-02-17 2012-08-30 Chiesi Farmaceutici S.P.A. Liquid propellant-free formulation comprising an antimuscarinic drug
RU2611627C2 (ru) 2011-04-29 2017-02-28 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Алкалоидный эфир и карбаматные производные и их медицинские композиции

Also Published As

Publication number Publication date
US20120004258A1 (en) 2012-01-05
GEP20135744B (en) 2013-02-11
ME01283A (fr) 2013-06-20
AU2009278306A1 (en) 2010-02-11
US20100035922A1 (en) 2010-02-11
US8404712B2 (en) 2013-03-26
EP2154136A1 (fr) 2010-02-17
EP2313404A1 (fr) 2011-04-27
US8039483B2 (en) 2011-10-18
UA102857C2 (en) 2013-08-27
CA2733380A1 (fr) 2010-02-11
AR072994A1 (es) 2010-10-06
WO2010015324A1 (fr) 2010-02-11
MY156332A (en) 2016-02-15
SI2313404T1 (sl) 2012-07-31
HRP20120394T1 (hr) 2012-06-30
ES2384914T3 (es) 2012-07-13
MX2011001504A (es) 2011-03-29
JO2831B1 (en) 2014-09-15
CY1112724T1 (el) 2016-02-10
ATE551341T1 (de) 2012-04-15
US20110319444A1 (en) 2011-12-29
IL211103A0 (en) 2011-04-28
CN102112474A (zh) 2011-06-29
CO6351790A2 (es) 2011-12-20
ZA201100963B (en) 2012-05-30
EA201100161A1 (ru) 2011-10-31
HK1156032A1 (en) 2012-06-01
IL211103A (en) 2014-04-30
PT2313404E (pt) 2012-07-02
PL2313404T3 (pl) 2012-09-28
RS52370B (en) 2012-12-31
JP2011530489A (ja) 2011-12-22
EA019166B1 (ru) 2014-01-30
KR20110044221A (ko) 2011-04-28
TWI455938B (zh) 2014-10-11
AU2009278306B2 (en) 2014-06-26
US8440690B2 (en) 2013-05-14
TW201011022A (en) 2010-03-16
DK2313404T3 (da) 2012-06-04
NZ590987A (en) 2012-11-30
CN102112474B (zh) 2014-01-29
EP2313404B1 (fr) 2012-03-28

Similar Documents

Publication Publication Date Title
MA32622B1 (fr) Derives de carbonate de quinuclidine et composition medicinale les comprenant
CY1121843T1 (el) Σκευασματα ετανερσεπτης σταθεροποιημενα με ιοντα μαγνησιου
CY1122853T1 (el) Σταθερα σκευασματα λινακλοτιδης
EA201190017A1 (ru) Аминоэфирные производные алкалоидов и их медицинские композиции
CY1123365T1 (el) Ενωσεις που εχουν δραστικοτητα ανταγωνιστη μουσκαρινικου υποδοχεα και αγωνιστη βητα2 αδρενεργικου υποδοχεα
CY1116328T1 (el) Παραγωγα 4 - αμινοπυριμιδινης και η χρηση τους ως ανταγωνιστων α2α υποδοχεων αδενοσινης
CL2012003604A1 (es) Compuestos heterociclicos derivados de piridina carboxamida sustituida; proceso de preparacion; composicion farmaceutica; combinacion farmaceutica; uso en el tratamiento de trastornos proliferativos celulares, enfermedad de parkinson, cancer, entre otros.
MY163055A (en) Polycyclic antagonists of lysophosphatidic acid receptors
IN2012DN02177A (fr)
IN2012DN02730A (fr)
IN2012DN00754A (fr)
ME01532B (me) Jedinjenja
EA201100691A1 (ru) Антагонисты рецепторов лизофосфатидной кислоты
CO6620050A2 (es) Derivados de aminopirimidina como moduladores de la lrrk2
BR112012027743A2 (pt) ciclopropil dicarboxamidas e análogos exibindo atividades anticâncer e antiproliferativas
DOP2010000234A (es) Antagonistas n,n-disustituidos de aminoalquilbifenilo de receptores d2 de prostaglandina
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
EA201190142A1 (ru) Производные пиразола, используемые в качестве антагонистов рецептора ccr4
EA201290394A1 (ru) Морфолинотиазолы в качестве позитивных аллостерических модуляторов альфа 7
PH12015501955B1 (en) Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
MX2014000964A (es) Derivados aza heterociclicos sustituidos.
MX347105B (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona.
EA201501163A1 (ru) Модуляторы рецептора cxcr7
MX337106B (es) Antagonistas no competitivos de receptores nicotinicos.